Studies on morphine disposition: influence of general anaesthesia on plasma concentrations of morphine and its metabolites
- PMID: 2917110
- DOI: 10.1093/bja/62.1.22
Studies on morphine disposition: influence of general anaesthesia on plasma concentrations of morphine and its metabolites
Abstract
The kinetics of morphine were studied during balanced anaesthesia in 10 patients undergoing lower abdominal or body surface surgery, and compared with those obtained in nine awake patients receiving morphine i.v. for the relief of chronic non-cancer pain. All patients received morphine sulfphate pentahydrate 10 mg i.v. over 30 s. Venous blood samples were collected for up to 180 min, and plasma concentrations of morphine, morphine-3-glucuronide (M3G), and morphine-6-glucuronide (M6G) assayed by a differential radioimmunoassay technique. There were no differences between groups with respect to the elimination half-life (awake group: 207 min; anaesthetized group: 153 min), volume of distribution at steady state (awake: 147 litre; anaesthetized: 128 litre), or clearance (awake: 587 ml min-1; anaesthetized: 766 ml min-1). Peak concentrations of M3G were similar in the two groups, but the peak concentration of M6G was greater in the anaesthetized patients. The AUC for M3G and M6G (0-180 min) also were greater in the anaesthetized patients, presumably as a result of decreases in renal blood flow and glomerular filtration rate during halothane anaesthesia.
Similar articles
-
Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites.Br J Anaesth. 1989 Jan;62(1):28-32. doi: 10.1093/bja/62.1.28. Br J Anaesth. 1989. PMID: 2644963
-
Studies on morphine disposition: plasma concentrations of morphine and its metabolites in anesthetized middle-aged and elderly surgical patients.J Clin Anesth. 1989;1(3):164-9. doi: 10.1016/0952-8180(89)90036-6. J Clin Anesth. 1989. PMID: 2627383
-
Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.Br J Clin Pharmacol. 1996 Jun;41(6):531-7. doi: 10.1046/j.1365-2125.1996.03539.x. Br J Clin Pharmacol. 1996. PMID: 8799518 Free PMC article. Clinical Trial.
-
Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.Br J Clin Pharmacol. 2002 Dec;54(6):592-603. doi: 10.1046/j.1365-2125.2002.t01-1-01689.x. Br J Clin Pharmacol. 2002. PMID: 12492606
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
Cited by
-
Pharmacokinetic drug interactions in anaesthetic practice.Clin Pharmacokinet. 1991 Oct;21(4):285-307. doi: 10.2165/00003088-199121040-00005. Clin Pharmacokinet. 1991. PMID: 1760901 Review.
-
Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.Br J Clin Pharmacol. 1999 Jul;48(1):37-42. doi: 10.1046/j.1365-2125.1999.00948.x. Br J Clin Pharmacol. 1999. PMID: 10383558 Free PMC article. Clinical Trial.
-
Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients.Ther Clin Risk Manag. 2007 Oct;3(5):961-7. Ther Clin Risk Manag. 2007. PMID: 18473019 Free PMC article.
-
Toward an Understanding of the Propensity for Crystalline Hydrate Formation by Molecular Compounds. Part 2.Cryst Growth Des. 2021 Sep 1;21(9):4927-4939. doi: 10.1021/acs.cgd.1c00353. Epub 2021 Jul 30. Cryst Growth Des. 2021. PMID: 34483749 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous